Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human immunodeficiency virus type 1 (HIV-1) polymerase polyprotein, commonly referred to as HIV-1 Pol, is a large precursor protein encoded by the pol gene of HIV-1. It is one of three major polyproteins produced by the virus (the others being Gag and Env) and plays a central role in viral replication and maturation. After translation, it is proteolytically cleaved by the viral protease into three key enzymes: Protease (PR), Reverse Transcriptase (RT), and Integrase (IN). These enzymes are responsible for cleaving viral precursor proteins, synthesizing DNA from the RNA genome, and integrating viral DNA into the host genome, respectively. The coordinated action of these enzymes enables HIV replication through several stages: assembly, maturation, and integration into host cells. All three enzyme products—PR, RT, IN—are major targets for antiretroviral drugs used in current HIV therapy regimens.
Inhibition of protease, reverse transcriptase, or integrase activity, preventing viral replication and maturation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Polymerase Polyprotein (HIV-1 Pol).